Charnwood Molecular have been selected as a finalist for the upcoming 2019 OBN Awards.
The company is celebrating after being announced as one of just four finalists in the “Best CRO” category. “We’d like to thank everyone on the team here at Charnwood Molecular and, of course, all of our clients, for your continued support” stated Steven Allin, Managing Director and Co-Founder of Charnwood Molecular. “It is testament to the efforts of all our team here at Charnwood Molecular that we are being considered for this award” he added. The 11th Annual OBN Awards remains the life sciences industry’s most highly regarded awards event. According to the organisers, entry rates increased once again this year, with the quality of entries and levels of innovation consistently impressive across all categories. The winners of the 2019 awards will be announced on 7th November at the Examination Schools in Central Oxford.